Publicacions en què col·labora amb María Aránzazu Tabernero Urbieta (7)

2021

  1. Erratum: Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo (Neuro-Oncology DOI: 10.1093/neuonc/noz243)

    Neuro-Oncology

2020

  1. Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

    Neuro-Oncology, Vol. 22, Núm. 4, pp. 493-504

2018

  1. Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 65, Núm. 4, pp. 1109-1124

2017

  1. A c-Src inhibitor peptide based on connexin43 exerts neuroprotective effects through the inhibition of glial hemichannel activity

    Frontiers in Molecular Neuroscience, Vol. 10

2016

  1. Aberrant co-localization of synaptic proteins promoted by Alzheimer's Disease amyloid-β peptides: Protective effect of human serum albumin

    Journal of Alzheimer's Disease, Vol. 55, Núm. 1, pp. 171-182

  2. Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes

    Oncotarget, Vol. 7, Núm. 31, pp. 49819-49833

2014

  1. Oleic acid synthesized by stearoyl-CoA desaturase (SCD-1) in the lateral periventricular zone of the developing rat brain mediates neuronal growth, migration and the arrangement of prospective synapses

    Brain Research, Vol. 1570, pp. 13-25